Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Curran

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|September 20, 2019
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV<sup>+</sup> oral cancerStephanie Dorta-Estremera, Venkatesh L Hegde, Ravaen B Slay, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic CancerAkash Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Neuro-Oncology|October 20, 2024
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?Ruochen Du, Jianzhong Zhang, Rimas V Lukas, et al.
F1000Research|November 3, 2022
cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade gliomaShashwat Tripathi, Hinda Najem, Akanksha Sanjay Mahajan, et al.
Cancer Research|July 29, 2018
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV<sup>+</sup> Oral CancersStephanie Dorta-Estremera, Renee L Chin, Gloria Sierra, et al.
Nature Metabolism|August 15, 2024
LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regenerationYalan Deng, Zilong Zhao, Marisela Sheldon, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent PathwayTodd Bartkowiak, Ashvin R Jaiswal, Casey R Ager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8<sup>+</sup> T-Cell-Driven Antitumor ImmunitySarah L Buchan, Mohannad Fallatah, Stephen M Thirdborough, et al.
Cancer Research Communications|March 13, 2024
Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid LeukemiaAkash R Boda, Arthur J Liu, Susana Castro-Pando, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|September 20, 2019
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV<sup>+</sup> oral cancerStephanie Dorta-Estremera, Venkatesh L Hegde, Ravaen B Slay, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic CancerAkash Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Neuro-Oncology|October 20, 2024
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?Ruochen Du, Jianzhong Zhang, Rimas V Lukas, et al.
F1000Research|November 3, 2022
cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade gliomaShashwat Tripathi, Hinda Najem, Akanksha Sanjay Mahajan, et al.
Cancer Research|July 29, 2018
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV<sup>+</sup> Oral CancersStephanie Dorta-Estremera, Renee L Chin, Gloria Sierra, et al.
Nature Metabolism|August 15, 2024
LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regenerationYalan Deng, Zilong Zhao, Marisela Sheldon, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent PathwayTodd Bartkowiak, Ashvin R Jaiswal, Casey R Ager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8<sup>+</sup> T-Cell-Driven Antitumor ImmunitySarah L Buchan, Mohannad Fallatah, Stephen M Thirdborough, et al.
Cancer Research Communications|March 13, 2024
Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid LeukemiaAkash R Boda, Arthur J Liu, Susana Castro-Pando, et al.
Pageof 9